On Monday shares of DS Healthcare Group, Inc. (NASDAQ:DSKX) closed at $1.64. Company’s sales growth for last 5 years was 30.80%. DS Healthcare Group, Inc. (NASDAQ:DSKX), announced it will soon begin selling to Farmacias Benavides, Mexico’s third largest pharmacy chain recently acquired by Alliance Boots GmbH, the European pharmacy retailer and wholesaler owned in part by Walgreens Co. (NASDAQ:WBA).
Schlumberger Limited (NYSE:SLB) in last trading activity fell -0.71% to close at $91.77. Company weekly performance is -1.30% while its quarterly performance stands at 6.93%. Schlumberger Limited (NYSE:SLB) is -21.63% away from its 52 week high. Schlumberger Limited (NYSE:SLB) will hold a conference call on July 17, 2015 to discuss the results for the second quarter ending June 30, 2015. The conference call is scheduled to begin at 9:00 am (US Eastern time), 2:00 pm (London time). A press release regarding the Company’s results will be issued on July
On last trading day Zebra Technologies Corporation (NASDAQ:ZBRA) advanced 0.30% to close at $93.06. Its volatility for the week is 1.95% while volatility for the month is 1.87%. ZBRA’s sales growth for past 5 years was 17.70% and its EPS growth for past 5 years was -5.10%. Zebra Technologies Corporation (NASDAQ:ZBRA) monthly performance is -2.51%. On May 5, Zebra Technologies Corporation (NASDAQ:ZBRA), announced the creation of a new channel partner program, which will enable and reward growth for Zebra’s channel partners who are investing in driving value for end user customers. Built with input from Zebra’s global partner ecosystem, the new program will also make it easier for channel partners to expand their relationship with Zebra and deliver innovative solutions to customers.
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) has 46.94% insider ownership while its institutional ownership stands at 29.50%. In last trading activity company’s stock closed at $7.64. Northwest Biotherapeutics (NASDAQ:NWBO) announced that Linda Powers, NW Bio CEO, presented a live overview of the Company’s DCVax cancer vaccine platform for solid tumor cancers and the Company’s multiple clinical programs at VirtualInvestorConferences.com on May 7, 2015.